Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Neovacs S.A.
ALNEVCurrent price
0.0002 EUR
-0.000099 EUR (-33.33%)
Last closed
0.0002 EUR
Company
www.neovacs.com
ISIN
FR00140077X1
Sector
Healthcare
Industry
Biotechnology
Exchange
Euronext Paris
Capitalization
287 984 EUR
Yield for 12 month
-99.99 %
1Y
3Y
5Y
10Y
15Y
ALNEV
Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for autoimmune diseases using its Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of lupus erythematosus; and Phase IIa clinical trial for the treatment of dermatomyositis; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company was founded in 1993 and is based in Paris, France. Address: 3-5, Impasse Reille, Paris, France, 75014
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1.05 EURP/E ratio
–Dividend Yield
–Current Year
+537 632 EUR
Last Year
+1 120 EUR
Current Quarter
+434 451 EUR
Last Quarter
+103 181 EUR
Current Year
-6 807 793 EUR
Last Year
-3 461 766 EUR
Current Quarter
-1 581 381 EUR
Last Quarter
-3 639 334 EUR
Key Figures ALNEV
1 year
3 years
5 years
10 years
EBITDA
-6 107 657 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-8.01 %
PEG Ratio
–
Return On Equity TTM
-17.66 %
Wall Street Target Price
1.05 EUR
Revenue TTM
537 632 EUR
Book Value
139.99 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
104.7 %
Dividend Yield
–
Gross Profit TTM
-3 419 445 EUR
Earnings per share
-25.06 EUR
Diluted Eps TTM
-25.06 EUR
Most Recent Quarter
IV 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ALNEV
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ALNEV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10000
Payout Ratio
–
Last Split Date
05.12.2024
Dividend Date
–
Stock Valuation ALNEV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.0122
Price Sales TTM
0.5357
Enterprise Value EBITDA
2.5306
Price Book MRQ
0.0039
Financials ALNEV
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ALNEV
For 52 weeks
0.0002 EUR
2.18 EUR
50 Day MA
0.0005 EUR
Shares Short Prior Month
–
200 Day MA
0.35 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart